A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Unlocking the untapped potential of intelligent automation in life sciences

by Shirish Gupta, senior manager, and Muna Tuna, senior manager, Deloitte Consulting LLP

Intelligent Automation (IA)—the combination of artificial intelligence and automation—is rapidly becoming mainstream in nearly every sector of our economy. Companies are using IA to improve operational efficiencies by performing repetitive tasks far more quickly and accurately. Beyond improvements in productivity, IA also can enable higher levels of business value through innovation and strategic growth.

While industries such as financial services and retail have tapped into the potential of IA,

Read more

Demonstrating and rewarding value in health care

by Jeff Morgan, Managing Director, Deloitte Consulting LLP

The growing importance of real world evidence and value-based contracting programs

As the cost of health care continues to rise, life sciences companies are facing mounting pricing pressure and a growing need to continuously demonstrate the value of their products in a real-world population. These market forces are driving more and more life sciences companies to invest in new capabilities with the goal of harnessing the power of real world data (RWD) and changing how value is both demonstrated and rewarded.

Read more

Moving value-based contracting from experimentation to common practice

by Jeff Morgan, Managing Director, Deloitte Consulting LLP

As the health care world continues its shift from volume- to value-based reimbursement, value-based contracts (VBC) between life sciences companies and payers that tie the reimbursement of a product to the value it delivers are gaining traction.

The health care system is going through a volume-to-value transformation with the goal of controlling cost and improving patient outcomes.

Read more

If disruption of the health care system is inevitable, will stakeholders work together?

by Margaret Anderson, Managing Director, Deloitte Consulting LLP

When it comes to their health care, many patients are becoming data scientists as they begin to gain access to data related to their health. In response to this data disruption, health plans, pharmaceutical companies, federal agencies, and nonprofits should develop tools and coaching services to help people get the most from their health data.

Read more

Life sciences outlook for 2019: Moving from the hypothetical into a new reality

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

As we step into the new year, the pace of change in life sciences feels like it is moving faster than ever. While trends in the industry generally take place over decades rather than years, many of the foundational elements to shift from treatment to wellness, for example, are beginning to take shape.

Several trends will likely continue to shape biopharmaceutical and medical device manufacturers in 2019.

Read more

Radical Interoperability: Let’s break down the barriers on health care information systems

by Dr. Douglas Rosendale, DO, FACOS, FACS, DO, FACOS, FACS Federal Chief Medical Interoperability Officer, Deloitte Consulting LLP

Maybe it’s because I spent my early career as a “cowboy surgeon” in Colorado, but I’ve always been a bit of a maverick when it comes to using technology to improve health care delivery and outcomes. I was chief of surgery at the Veterans Administration when I founded and chaired the Health IT Innovation Development program under the White House Office of Science and Technology Policy to develop radical,

Read more